Focused ultrasound-mediated drug delivery through the blood-brain barrier

Expert Review of Neurotherapeutics

Volumn 15, Issue 5, 2015, Pages 477-491

  Burgess, Alison ^a   Shah, Kairavi ^a   Hough, Olivia ^a   Hynynen, Kullervo ^a,b  

^a Sunnybrook Health Sciences Centre   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

blood brain barrier; drug delivery; focused ultrasound; neurodegenerative disease

Indexed keywords

CARRIER PROTEIN;

BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; MEMBRANE PERMEABILITY; MICROBUBBLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; REVIEW; ANIMAL; BRAIN; PATHOLOGY; PROCEDURES; ULTRASOUND;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; DRUG DELIVERY SYSTEMS; HUMANS; MAGNETIC RESONANCE IMAGING; MICROBUBBLES; ULTRASONIC WAVES;

EID: 84928888170     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.2015.1028369     Document Type: Review

References (121)

1. Ussing HH. The distinction by means of tracers between active transport and diffusion. Acta Physiol Scand 1949;19: 43-56
2. Michel C. Transport of fluids and solutes in tissues. In: Bader D, Bouten C, Colin D, et al. editors. Pressure ulcer research. Springer Berlin Heidelberg; New York, USA: 2005. p. 233-62
3. Mann GE, Zlokovic BV, Yudilevich DL. Evidence for a lactate transport system in the sarcolemmal membrane of the perfused rabbit heart: kinetics of unidirectional influx, carrier specificity and effects of glucagon. Biochim Biophys Acta 1985;819: 241-8
4. Zlokovic BV, Segal MB, Begley DJ, et al. Permeability of the blood cerebrospinal fluid and blood brain barriers to thyrotropin releasing hormone. Brain Res 1985;358: 191-9
5. Zlokovic BV, Begley DJ, Chain Eliash DG. Blood brain barrier permeability to leucine-enkephalin, D-alanine2-D-leucine5-enkephalin and their N-terminal amino acid (tyrosine). Brain Res 1985;336:125-32
6. Zlokovic BV, Hyman S, McComb JG, et al. Kinetics of arginine-vasopressin uptake at the blood-brain barrier. Biochim Biophys Acta 1990;1025:191-8
7. Zlokovic BV, Lipovac MN, Begley DJ, et al. Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea pig brain. J Neurochem 1987;49: 310-15
8. Zlokovic BV. Cerebrovascular permeability to peptides: manipulations of transport systems at the blood-brain barrier. Pharm Res 1995;12(10):1395-406
9. Ehrlich P. Das sauerstoff-bedürfnis des organismus. In: Ehrlich P, editor. Eine farbenanalytische studie. Berlin; Germany: 1885
10. Ehrlich P. Ueber die beziehungen von chemischer constitution, verteilung und pharmakologischer wirkung. In: Ehrlich P, editor. Gesammelte Arbeiten zur Immunitaetsforschung. Berlin; Germany: 1904. p. 574
11. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2006;57:173-85
12. Clark DD, Sokoloff L. Circulation and energy metabolism of the brain. In: Siegel GJ, Agranoff BW, Albers RW, et al. editors. Molecular, cellular and medical aspects. 6th edition. Lippincott-Raven; Philadelphia, USA: 1999. p. 637-70
13. Lewandowsky M. Zur lehre von der cerebrospinalflussigkeit. Z Klin Med 1900;40:480-94
14. Goldmann EE. Vitalfarbung am zentralnervensystem. Abh Preuss Akad Wiss 1913;1:1-60
15. Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1900;34: 207-17
16. Yudilevich DL, De Rose N. Blood-brain transfer of glucose and other molecules measured by rapid indicator dilution. Am J Physiol 1971;220:841-6
17. Davson H. The blood-brain barrier. J Physiol 1976;255:1-28
18. Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2005;2:3-14
19. Saitou M, Furuse M, Sasaki H, et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000;11:4131-42
20. Nitta T, Hata M, Gotoh S, et al. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 2003;161(3):653-60
21. Clark DE. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci 1999;87:815-21
22. Begley DJ. ABC transporters and the blood-brain barrier. Curr Pharm Des 2004;10:1295-312
23. Ben-Zvi A, Lacoste B, Kur E, et al. Mfsd2a is critical for the formation and function of the blood-brain barrier. Nature 2014; 509(7501):507-11
24. Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med 2013; 19(12):1584-96
25. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 2002;200(6):629-38
26. Abbott NJ, Rönbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53
27. Tonra JR. Cerebellar susceptibility to experimental autoimmune encephalomyelitis in SJL/J mice: potential interaction of immunology with vascular anatomy. Cerebellum 2002;1:57-68
28. Alvarez JI, Dodelet-Devillers A, Kebir H, et al. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 2011; 334(6063):1727-31
29. Wosik K, Cayrol R, Dodelet-Devillers A, et al. Angiotensin II controls occludin function and is required for blood brain barrier maintenance: relevance to multiple sclerosis. J Neurosci 2007;27(34):9032-42
30. Yao Y, Chen Z, Norris EH, Strickland S. Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. Nat Commun 2014; 5(3413):1-12
31. Bell RD, Winkler EA, Singh I, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 2012;485:512-16
32. Daneman R, Zhou L, Kebede AA, et al. Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 2010;468:562-6
33. Bell RD, Winkler EA, Sagare AP, et al. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron 2010;68(3):409-27
34. Armulik A, Genove G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011;21(2):193-215
35. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008;57(2):178-201
36. Kortekaas R, Leenders KL, van Oostrom JC, et al. Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 2005;57:176-9
37. Sagare AP, Bell RD, Zhao Z, et al. Pericyte loss influences Alzheimer-like neurodegeneration in mice. Nat Commun 2013;4:2932
38. Deane R, Wu Z, Sagare A, et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 2004;43:333-44
39. Deane R, Singh I, Sagare AP, et al. A multimodal RAGE-specific inhibitor reduces amyloid J3-mediated brain disorder in a mouse model of Alzheimer disease. J Clin Invest 2012;122:1377-92
40. Winkler EA, Sengillo JD, Bell RD, et al. Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability. J Cereb Blood Flow Metab 2012;32(10): 1841-52
41. Winkler EA, Sengillo JD, Sagare AP, et al. Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc Natl Acad Sci USA 2014;111(11):1035
42. Gross ME, Nelson ET, Mone MC, et al. A comparison of postoperative outcomes utilizing a continuous preperitoneal infusion versus epidural for midline laparotomy. Am J Surg 2011;202(6):765-70
43. Fishman RA, Christy NP. Fate of adrenal cortical steroids following intrathecal injection. Neurology 1965;15:1-6
44. Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab 2012;32:1959-72
45. Rapoport S. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy. Expert Opin Investig Drugs 2001;10:1809-18
46. Matsukado K, Sugita M. Intracarotid low dose bradykinin infusion selectively increases tumor permeability through activation of bradykinin B2 receptors in malignant gliomas. Brain Res 1998;792:10-15
47. Pardridge WM, Oldendorg WH. Kinetics of blood-brain barrier transport of hexoses. Biochim Biophys Acta Biomem 1975;282: 377-92
48. Killian DM, Hermeling S, Chikhale PJ. Targeting the cerebrovascular large neutral amino acid transporter (LAT1) isoform using a novel disulfide-based brain drug delivery system. Drug Deliv 2007;14(1): 25-31
49. Pardridge WM, Boado RJ. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Methods Enzymol 2012;503:274-8
50. Jadhav AS, Pathare DB, Shigare MS. Development and validation of enantioselective high performance liquid chromatographic method for Valacyclovir, an antiviral drug in drug substance. J Pharm Biomed Anal 2007;43(4):1568-72
51. Kristensson K, Olsson Y. Uptake and retrograde axonal transport of peroxidase in hypoglossal neurons. Acta Neuropathol 1971;19:1-9
52. Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev 2012;64: 614-28
53. Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001;220:640-6
54. Vykhodtseva NI, Hynynen K, Damianou C. Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med Biol 1995;21:969-79
55. Vykhodtseva N, MacDannold N, Hynynen K. Progress and problems in the application of focused ultrasound for blood-brain barrier disruption. Ultrasonics 2008;48:279-96
56. Hynynen K. MRI-guided focused ultrasound treatments. Ultrasonics 2010; 50(2):221-9
57. Treat LH, McDannold N, Vykhodtseva N, et al. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 2007;121:901-7
58. McDannold N, Vykhodtseva N, Hynynen K. Blood-brain disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med Biol 2008;34:834-40
59. Bing KF. The potential for ultrasonic image-guided therapy using a diagnostic system. Dissertation Duke University; Durham: 2008
60. McDannold N, Vykhodtseva N, Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med. Biol 2008;34:930-7
61. Choi JJ, Selert K, Gao Z, et al. Noninvasive and localized blood-brain barrier disruption using focused ultrasound can be achieved at short pulse lengths and low pulse repetition frequencies. J Cereb Blood Flow Metab 2011;31:725-37
62. O'Reilly MA, Waspe AC, Ganguly M, Hynynen K. Closely-timed short pulses: influence of sonication parameters and injection rate. Ultrasound Med Biol 2011;37:587-94
63. Samiotaki G, Konofagou EE. Dependence of the reversibility of focused-ultrasound-induced blood-brain barrier opening on pressure and pulse length in vivo. IEEE Trans Ultrason Ferroelectr Freq Control 2013;60:2257-65
64. Goertz DE, Wright C, Hynynen K. Contrast agent kinetics in the rabbit brain during exposure to therapeutic ultrasound. Ultrasound Med Biol 2010;36:916-24
65. McDannold N, Vykhodtseva N, Hynynen K. Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study. Ultrasound Med Biol 2007;33(4): 584-90
66. Yang F, Fu W, Chen W, et al. Quantitative evaluation of the use of microbubbles with transcranial focused ultrasound on blood-brain-barrier disruption. Ultrason Sonochem 2008;15:636-43
67. Weng J, Wu S, Yang F, et al. Pulse sequence and timing of contrast-enhanced MRI for assessing blood-brain barrier disruption after transcranial focused ultrasound in the presence of hemorrhage. J Magn Reson Imaging 2010;31:1323-30
68. Choi JJ, Feshitan JA, Baseri B, et al. Microbubble-size dependence of focused ultrasound-induced blood-brain barrier opening in mice in vivo. IEEE Trans Biomed Eng 2010;54:145-54
69. Vlachos F, Tung Y, Konofagou E. Permeability dependence study of the focused ultrasound-induced blood-brain barrier opening at distinct pressures and microbubble diameters using DCE-MRI. Magnet Reson Med 2011;66:821-30
70. Wang S, Samiotaki G, Olumolade O, et al. Microbubble type and distribution dependence of focused ultrasound-induced blood-brain barrier opening. Ultrasound Med Biol 2014;40:130-7
71. Alkins RD, Broderson PM, Sodhi RNS, Hynynen K. Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound. Neuro Oncol 2013;15:1225-35
72. Jordão JF, Ayala-Grosso CA, Markham K, et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease. PLoS One 2010;5:e10549
73. McDannold N, Vykhodtseva N, Raymond S, et al. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol 2005;31(11):1527-37
74. McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res 2012; 72(14):3652-63
75. Burgess A, Hynynen K. Drug delivery across the blood-brain barrier using focused ultrasound. Expert Opin Drug Deliv 2014;11:711-21
76. Scarcelli T, Jordão JF, O'Reilly MA, et al. Stimulation of hippocampal neurogenesis by transcranial focused ultrasound and microbubbles in adult mice. Brain Stimul 2014;7:304-7
77. Hosseinkhah N, Hynynen K. A three-dimensional model of an ultrasound contrast agent gas bubble and its mechanical effects on microvessels. Phys Med Biol 2012;57(3):785-808
78. Krizanac-Bengez L, Mayberg MR, Janigro D. The cerebral vasculature as a therapeutic target for neurological disorders and the role of shear stress in vascular homeostatis and pathophysiology. Neurol Res 2004;26(8):846-53
79. Chen H, Kreider W, Brayman AA, et al. Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett 2011;106(3):034301
80. Nyborg WL. Biological effects of ultrasound: development of safety guidelines. Part II: general review. Ultrasound Med Biol 2001;27:301-33
81. Traub O, Ishida T, Ishida M, et al. Shear stress-mediated extracellular signal-regulated kinase activation is regulated by sodium in endothelial cells. Potential role for a voltage-dependent sodium channel. J Biol Chem 1999;274(29):20144-50
82. O'Reilly MA, Hynynen K. Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. Radiology 2012; 263: 96-106
83. Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N. Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring. PLoS One 2012;7:e45783
84. Wu SY, Tung YS, Marquet F, et al. Transcranial cavitation detection in primates during blood-brain barrier opening-a performance assessment study. IEEE Trans Ultrason Ferroelectr Freq Control 2014; 61(6):966-78
85. Van Rooij T, Luan Y, Renaud G, et al. Response to ultrasound of two types of lipid-coated microbubbles observed with a high-speed optical camera. J Acoust Soc Am 2014;135:2370
86. Sheikov N, McDannold N, Vykhodtseva N, et al. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 2004;30:979-89
87. Sheikov N, McDannold N, Sharma S, Hynynen K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 2008;34:1093-104
88. Sheikov N, McDannold N, Jolesz F, et al. Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound Med Biol 2006;32:1399-409
89. Lionetti V, Fittipaldi A, Agostini S, et al. Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. Ultrasound Med Biol 2009;35:136-43
90. Deng J, Huang Q, Wang F, et al. The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles. J Mol Neurosci 2012;46:677-87
91. Choi JJ, Pernot M, Brown TR, et al. Spatio-temporal analysis of molecular delivery through the blood-brain barrier using focused ultrasound. Phys Med Biol 2007;52(18):5509-30
92. Cho EE, Drazic J, Ganguly M, et al. Two-photon fluorescence microscopy study of cerebrovascular dynamics in ultrasound-induced blood-brain barrier opening. J Cereb Blood Flow Metab 2011; 31(9):1852-62
93. Raymond SB, Treat LH, Dewey JD, et al. Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse models. 2008; 3(5):e2175
94. Jordao JF, Thevenot E, Markham-Coultes K, et al. Amyloid-J3 plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp Neurol 2013;248:16-29
95. Jalali S, Huang Y, Dumont DJ, Hynynen K. Focused ultrasound-mediated bbb disruption is associated with an increase in activation of AKT: experimental study in rats. BMC Neurol 2010;10:114-24
96. Tufail Y, Matyushov A, Baldwin N, et al. Transcranial pulsed ultrasound stimulates intact brain circuits. Neuron 2010;66: 681-94
97. Marquet F, Wu S, Tung Y, et al. Real-time, transcranial monitoring of safe blood-brain barrier opening in non-human primates. PLoS One 2014;9:e84310
98. Tung Y, Wu S, Marquet F, Konofagou EE. Quantification of stable cavitation dose during FUS-induced blood-brain barrier opening in mice and in non-human primates. Int Ultrason Symp 2012:244-7
99. McDannold N, Vykhodtseva N, Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol 2006;51:793-807
100. Coluccia D, Fandino J, Schwyzer L, et al. First noninvasive thermal ablation of a brain tumor with MR-guided focused ultrasound. J Ther Ultrasound 2014:2-17
101. Hynynen K. Human brain's ultimate barrier to open for first time: It's neuroscience's final frontier. Tiny bubbles will open the blood-brain barrier to sneak drugs into tumours-and we might treat Alzheimer's the same way. New Scientist. 2014
102. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Targeted delivery of antibodies through the blood-brain barrier by MRI-guided focused ultrasound. Biochem Biophys Res Commun 2006;340:1085-90
103. Kinoshita M, McDannold N, Jolesz FA, Hynynen K. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc Natl Acad Sci USA 2006;103:11719-23
104. Park EJ, Zhang YZ, Vykhodtseva N, McDannold N. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release 2012;163:277-84
105. Burgess A, Huang Y, Querbes W, et al. Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. J Control Release 2012;163: 125-9
106. Wang HB, Yang L, Wu J, et al. Reduced ischemic injury ater stroke in mice by angiogenic gene delivery via ultrasound targeted microbubble destruction. J Neuropathol Exp Neurol 2014;73:548-58
107. Thevenot E, Jordao JF, O'Reilly MA, et al. Targeted delivery of scAAV9 to the brain using MRI-guided focused ultrasound. Human Gene Ther 2012;23:1144-55
108. Hsu PH, Wei KC, Huang CY, et al. Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound. PLoS One 2013;8: e57682
109. Treat LH, McDannold N, Zhang Y Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 2012;38:1716-25
110. Aryal M, Vykhodtseva N, Zhang YZ. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release 2013;169:103-11
111. Kovacs Z, Werner B, Rassi A, et al. Prolonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse models. J Control Release 2014;187:74-82
112. Mei J, Cheng Y, Song Y, et al. Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound. J Ultrasound Med 2009;28: 871-80
113. Liu HL, Hua MY, Yang HW, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc Natl Acad Sci USA 2010;107: 15205-10
114. Fan CH, Ting CY, Liu HL, et al. Antiangiogenic drug-loaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials 2013;34: 2142-55
115. Chen PY, Liu HL, Hua MY, et al. Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol 2010;12: 1050-60
116. Ting CY, Fan CH, Liu HL, et al. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 2012;33:704-12
117. Timbie K, Burke C, Nance E, et al. Ultrasound-targeted delivery of systemically administered therapeutic nanoparticles. J Acoust Soc Am 2013;134:4047
118. Etame AB, Diaz RJ, O'Reilly MA, et al. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomed 2012;8:1133-42
119. Diaz RJ, McVeigh PZ, O'Reilly MA, et al. Focused ultrasound delivery of Raman naonparticles across the blood-brain barrier: potential for targeting experimental brain tumors. Nanomedicine 2014;10:1075-87
120. Burgess A, Ayala-Grosso CA, Ganguly M, et al. Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. PLoS One 2011;6:e27877
121. Alkins R, Burgess A, Ganguly M, et al. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res 2013;73:1892-9